Publication

A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphoma

Downloadable Content

Persistent URL
Last modified
  • 03/03/2025
Type of Material
Authors
    Jonathon Cohen, Emory UniversityKami J. Maddocks, Ohio State UniversityYing Huang, Ohio State UniversityBeth A. Christian, Ohio State UniversitySamantha M. Jaglowski, Ohio State UniversityChristopher Flowers, Emory UniversityKristie Blum, Emory University
Language
  • English
Date
  • 2017-01-01
Publisher
  • Taylor & Francis
Publication Version
Copyright Statement
  • © 2017 Informa UK Limited
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1042-8194
Volume
  • 58
Issue
  • 9
Start Page
  • 2268
End Page
  • 2269
Grant/Funding Information
  • This study was an investigator initiated study with funding provided by Takeda Pharmaceuticals.
Supplemental Material (URL)
Author Notes
  • Jonathon B. Cohen jonathan.cohen@emory.edu Department of Hematology and Medical Oncology, Emory University – Winship Cancer Institute, 1365C Clifton Road, NE, Atlanta, GA 30322, USA
Keywords
Research Categories
  • Health Sciences, Oncology

Tools

Relations

In Collection:

Items

Thumbnail Title File Description Date Uploaded Visibility Actions
file details Publication File - s4srg.pdf Primary Content 2025-02-28 Public Download